MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-11-0003122
Hemodiaz Life Sciences Private Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹59.98 Cr
▲ 57% YoY
Net profit · FY 2025
₹37.29 Lakh
Net margin 0.6%
EBITDA · FY 2025
₹2.16 Cr
EBITDA margin 3.6%
Authorised capital
₹1.5 Cr
Registered with MCA
Paid-up capital
₹1.06 Cr
Issued & subscribed
Open charges
₹15.53 Cr
Satisfied ₹6.79 Cr
Company age
28 yrs
Est. 1998
Employees · EPFO
1
Provident fund records
About Hemodiaz Life Sciences Private Limited
Data last updated:
Hemodiaz Life Sciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 24 July 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33111DL1998PTC095173. Its GSTIN is 07AADCS9727N1ZO (Delhi). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.06 Cr. It was formerly known as Shri Behari Lal Polymers Private Limited. and Shri Behari Lal Polymers Private Limited. It is led by directors including Vipin Dhawan and Ishita Dhawan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 324 Shiv Vihar West (Behind Sai Baba Mandr) Vikas Nagar, New Delhi, Delhi, India – 110059.
As per the financials filed for FY 2025, the company reported a revenue of ₹59.98 Cr, a growth of 57% compared to the previous year. For the same year it recorded a net profit of ₹37.29 Lakh (net margin 0.6%) and EBITDA of ₹2.16 Cr (EBITDA margin 3.6%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 6% over five years.
The company has about 1 employee on its provident fund (EPFO) records.
The company is associated with 1 brand: Hemodiaz. As per MCA filings, the company has open charges of ₹15.53 Cr and satisfied charges of ₹6.79 Cr on record. Court records list 88 cases involving the company, including 86 filed by the company and 2 filed against it; 26 cases are pending. The company has 7 deals on record (4 secondary share transfers, 2 rights issues, 1 funding round), with disclosed funding of ₹27.8 Lakh; the latest was in December 2021. Its 7 peer companies in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 3 larger and 4 smaller; the largest is Axess Medicom Private Limited with revenue of ₹60.57 Cr.
Hemodiaz Life Sciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0003122). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hemodiazlifesciences.in.
Company details
CIN U33111DL1998PTC095173
Registration Number 095173
Incorporation Date 24 July 1998
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-11-0003122
Name history
Hemodiaz Life Sciences has undergone 2 name changes throughout its history. The company was previously known as Shri Behari Lal Polymers Private Limited., and Shri Behari Lal Polymers Private Limited. The current legal name is Hemodiaz Life Sciences Private Limited.
| Company Name | Status |
|---|---|
| Hemodiaz Life Sciences Private Limited | Current |
| Shri Behari Lal Polymers Private Limited. | Previous |
| Shri Behari Lal Polymers Private Limited | Previous |
CIN history
Hemodiaz Life Sciences has one previous CIN (Corporate Identification Number): U24119DL1998PTC095173. The current CIN is U33111DL1998PTC095173, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U33111DL1998PTC095173 | Current |
| U24119DL1998PTC095173 | Previous |
Recognitions & Rankings of Hemodiaz Life Sciences
Contact details
Hemodiaz Life Sciences Private Limited's registered office is in New Delhi, Delhi. Its website is hemodiazlifesciences.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. 324 Shiv Vihar West (Behind Sai Baba Mandr) Vikas Nagar, New Delhi, Delhi, India – 110059
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Hemodiaz Life Sciences Private Limited, buy the company report.
Comprehensive company report
Hemodiaz Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Hemodiaz Life Sciences operates one associated brand: Hemodiaz. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and sells medical devices, supplies, and treatments online. | hemodiaz.com |
Business activity
The main business activity of Hemodiaz Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Hemodiaz Life Sciences Private Limited, buy the company report.
Financials of Hemodiaz Life Sciences Private Limited
FY 2025 filings availableHemodiaz Life Sciences Private Limited reported revenue of ₹59.98 Cr (up 57% YoY) for FY 2025.
Revenue · FY 2025
₹59.98 Cr ▲ 57%
Net profit · FY 2025
₹37.29 Lakh margin 0.6%
EBITDA · FY 2025
₹2.16 Cr margin 3.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 57%
3 years · compounded
▼ 3%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▲ 20%
3 years · compounded
▲ 9%
5 years · compounded
▲ 13%
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 57% growth in the latest year. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.16 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹37.29 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.6% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hemodiaz Life Sciences Private Limited, buy the company report.
Board of directors of Hemodiaz Life Sciences Private Limited
Hemodiaz Life Sciences has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vipin Dhawan Also directs: Asd Ad Media Solutions Private Limited | Director | 30 May 2025 | 1 Years 4 Months | Current |
| Ishita Dhawan | Director | 10 Sep 2025 | 1 Years 1 Months | Current |
| Shilpa Kapoor Also directs: Asd Ad Media Solutions Private Limited | Director | 08 Aug 2025 | 1 Years 2 Months | Current |
Peer comparison
Hemodiaz Life Sciences Private Limited is compared with the 7 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Axess Medicom Private Limited | ₹60.57 Cr (FY 2025) | 27.0% | Bhubaneswar, Odisha, India | |||
| Otic Hearing Solutions Private Limited | ₹60.25 Cr (FY 2024) | 7.0% | Navi Mumbai, Maharashtra, India | |||
| Zil Pharma Enterprises Private Limited | ₹60.12 Cr (FY 2025) | 44.0% | Mumbai, Maharashtra, India | |||
| Hemodiaz Life Sciences Private Limitedthis company | ₹59.98 Cr (FY 2025) | ₹37.29 Lakh | 0.6% | 57.0% | 1 | New Delhi, Delhi, India |
| June Enterprises Private Limited | ₹59.18 Cr (FY 2024) | 4.0% | Navi Mumbai, Maharashtra, India | |||
| Bishak Pharma Private Limited | ₹58.84 Cr (FY 2025) | 31.0% | Hyderabad, Telangana, India | |||
| Embee Diagnostics Private Limited | ₹58.29 Cr (FY 2024) | 9.0% | New Delhi, Delhi, India | |||
| Lifetech Scientific India Private Limited | ₹57.89 Cr (FY 2024) | 26.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Hemodiaz Life Sciences Private Limited, buy the company report.
Auditor
Hemodiaz Life Sciences Private Limited is audited by M S A AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M S A AND ASSOCIATES | FY 2023 | 009717N |
Shareholding
The shareholding of Hemodiaz Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Hemodiaz Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹15.53 Cr
Satisfied charges
₹6.79 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Oct 2021 | 100501642 | Others | ₹76 Lakh | Open | |
| 27 Apr 2021 | 100486832 | Others | ₹27.27 Lakh | Open | |
| 14 Jul 2012 | 10371883 | Others | ₹14.5 Cr | Open | |
| 17 Jul 2020 | 100350962 | Others | ₹1.54 Cr | Satisfied | |
| 13 Apr 2020 | 100333508 | Others | ₹80 Lakh | Satisfied |
To see the full charge records of Hemodiaz Life Sciences Private Limited, buy the company report.
Total charge records: 7 View all charges
Deals & funding
Hemodiaz Life Sciences Private Limited has 7 deals on record (4 secondary share transfers, 2 rights issues, 1 funding round), with disclosed funding of ₹27.8 Lakh; the latest was in December 2021.
Total deals
7
Secondary share transfers
4
Rights issues
2
Funding round
1
Disclosed funding
₹27.8 Lakh
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2020 | Rights issue | ₹19 Lakh | Investors: 2 individuals |
| Aug 2013 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Shri Ram Tradecom Private Limited , Somnath Buildcon Private Limited , Vidhan Infrastructure Private Limited |
| Jan 2012 | Secondary share transfer | Undisclosed | Buyer: Vipin Dhawan Huf, an individual Seller: Kuber Jewels Limited, Ruchi Chemicals Private Limited , Prateek Securities Private Limited |
| Mar 2011 | Funding round | ₹27.8 Lakh | Investors: Shri Ram Tradecom Private Limited , Somnath Buildcon Private Limited , Vidhan Infrastructure Private Limited |
To see the full deal history of Hemodiaz Life Sciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Hemodiaz Life Sciences Private Limited has 88 court cases on record: 86 filed by Hemodiaz Life Sciences, 2 filed against it. 26 cases are pending and 62 are disposed.
Total cases
88
Filed by the company
86
Filed against the company
2
Pending
26
Disposed
62
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 88 | 2 | 26 |
Cases on record (5 of 88)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North West, Delhi | Cheque dishonour complaint | Filed by the company against M/S Nareena Life Sciences Pvt. Ltd. and 2 others | Pending |
| District court, North West, Delhi | Cheque dishonour complaint | Filed by the company against M/S Blueneck Hospitec LLP and 2 others | Disposed |
| District court, North West, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, South West, Delhi | Civil suit | Filed by the company against an individual | Pending |
| District court, North West, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
To see the full case history of Hemodiaz Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Hemodiaz Life Sciences Private Limited was last rated by Care on 24 Sep 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 24 Sep 2021 |
To see the full credit ratings and regulatory alerts of Hemodiaz Life Sciences Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hemodiaz Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Hemodiaz Life Sciences Private Limited has a workforce of 1 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
Employee count
1
Active EPFO establishments
1
GST
Hemodiaz Life Sciences has 4 GST registrations: 2 active and 2 cancelled or inactive.
Total GSTINs
4
Active
2
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCS9727N1ZO | Delhi | Active | 01 Jul 2017 |
| 03AADCS9727N2ZV | Punjab | Active | 03 Oct 2020 |
To see the full GST registrations and return filing status of Hemodiaz Life Sciences Private Limited, buy the company report.
Recent activity
Hemodiaz Life Sciences Private Limited has 7 board changes on record since 1999: 5 appointments and 2 cessations. The latest: Ishita Dhawan was appointed as Director on 10 Sep 2025.
AGM
Hemodiaz Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Ishita Dhawan was appointed as Director.
Appointed
Shilpa Kapoor was appointed as Director.
Charges
A charge registered on 17 Jul 2020 via Charge ID 100350962 with Others was fully satisfied on 22 Jul 2025.
Charges
A charge registered on 13 Apr 2020 via Charge ID 100333508 with Others was fully satisfied on 22 Jul 2025.
Charges
A charge registered on 14 Jul 2012 via Charge ID 10371882 with Others was fully satisfied on 22 Jul 2025.
Appointed
Vipin Dhawan was appointed as Director.
Filing
Hemodiaz Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Others of Rs. 14.50 Cr registered on 14 Jul 2012 with Charge ID 10371883 was modified on 29 Mar 2025.
Charges
A charge with Others amounted to Rs. 0.76 Cr with Charge ID 100501642 was registered on 26 Oct 2021.
Charges
A charge with Others amounted to Rs. 0.27 Cr with Charge ID 100486832 was registered on 27 Apr 2021.
Charges
A charge with Others amounted to Rs. 1.54 Cr with Charge ID 100350962 was registered on 17 Jul 2020.
11 earlier events are in the company report.
Frequently asked questions
Hemodiaz Life Sciences is an active private limited company based in New Delhi, Delhi, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 24 July 1998 (28+ years old) and is registered under CIN U33111DL1998PTC095173.
Hemodiaz Life Sciences has 3 current directors:
- Vipin Dhawan - Director
- Ishita Dhawan - Director
- Shilpa Kapoor - Director
The latest financial statements of Hemodiaz Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Hemodiaz Life Sciences is 07AADCS9727N1ZO, registered in Delhi. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 03AADCS9727N2ZV (Punjab).
The CIN (Corporate Identification Number) of Hemodiaz Life Sciences is U33111DL1998PTC095173. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hemodiaz Life Sciences has 88 court cases on record: 86 filed by the company and 2 filed against it. 26 are pending.
Hemodiaz Life Sciences was incorporated on 24 July 1998, making it 28+ years old. It is registered with the Registrar of Companies, Delhi.
Hemodiaz Life Sciences has 7 deals on record (4 secondary share transfers, 2 rights issues, 1 funding round), with disclosed funding of ₹27.8 Lakh; the latest was in December 2021.
The peers of Hemodiaz Life Sciences by revenue are Axess Medicom Private Limited, Otic Hearing Solutions Private Limited, Zil Pharma Enterprises Private Limited, June Enterprises Private Limited, Bishak Pharma Private Limited and 2 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading).
Ishita Dhawan was appointed as Director on 10 Sep 2025. Shilpa Kapoor was appointed as Director on 08 Aug 2025. Vipin Dhawan was appointed as Director on 30 May 2025. Hemodiaz Life Sciences has 7 board changes on record in total.
Yes, Hemodiaz Life Sciences is registered as a small enterprise under Udyam registration (number: UDYAM-DL-11-0003122).